The Predictive Value of Microalbuminuriq in IPPM: A five-year follow-up study
The DOI matches its Crossref record.
Abstract
OBJECTIVE: To investigate the predictive value of microalbuminuria and the annual increase of albumin excretion as risk factors for diabetic nephropathy. RESEARCH DESIGN AND METHODS: A 5-year follow-up of patients with microalbuminuria (urinary albumin excretion [UAE\ = 30-299 mg/24 h) and matched patients with normoalbuminuria (UAE < 30 mg/24 h). The initial classification was based on one single 24-h urine collection. The annual increase in UAE was calculated by linear regression analysis of log-transformed UAE on time. This study was conducted at the outpatient clinic of the Steno Diabetes Center. The study subjects included 118 insulin-dependent diabetes mellitus (IDDM) patients between 18 and 50 years of age with microalbuminuria and 112 matched control patients with normal UAE with an age at diabetes onset of <31 years. The main outcome measures were UAE, annual change in UAE rate (percentage per year), and the prevalence of retinopathy. RESULTS: After 5 years, 39 (33%, 24-42 CI [95% confidence interval]) patients with microalbuminuria had normoalbuminuria, 57 (48%, 38-57 CI) still had microalbuminuria, and 22 (19%, 12-27 CI) had developed diabetic nephropathy. Among the 112 patients with normoalbuminuria in 1985, 9 (8%, 4-15 CI) had developed microalbuminuria, and 2 (2%, 0-6 CI) had developed diabetic nephropathy. Of the 79 patients with persistent albuminuria, only 36 (46%, 34-57 CI) were progressors with a rate of progression of >5%/year. Progressors had significantly higher HbA1c, higher mean blood pressure, and a higher incidence of proliferative retinopathy compared with nonprogressors. Multiple regression analysis only identified mean HbA1c as an independent predictor of the rate of progression. Smoking was significantly more prevalent in patients with persistent albuminuria. CONCLUSIONS: Microalbuminuria is a predictor of progression to diabetic nephropathy; however, not as strong as suggested previously. Calculation of the annual increase in UAE seems to be a more specific method of identifying patients who will develop diabetic nephropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Decreasing Incidence of Severe Diabetic Microangiopathy in Type 1 Diabetes
Hovind, P., Tarnow, L., Rossing, K., Rossing, P., Eising, S., Larsen, N., Binder, C., & Parving, H.-H. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1258 · Cited by 376
Laffel, L. M. B., McGill, J. B., & Gans, D. J. (1995) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)80226-5 · Cited by 279
Diabetic nephropathy in type II diabetes
Ritz, E., & Stefanski, A. (1996) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(96)90538-7 · Cited by 261
Care of diabetes in children and adolescents: controversies, changes, and consensus
Cameron, F. J., & Wherrett, D. K. (2015) · The Lancet · doi:10.1016/s0140-6736(15)60971-0 · Cited by 99
Influence of microalbuminuria in achieving blood pressure goals
Duka, I., & Bakris, G. (2008) · Current Opinion in Nephrology and Hypertension · doi:10.1097/mnh.0b013e328309a497 · Cited by 18
Metadata
- Authors
- Almdal, T., Nörgaard, K., Feldt-Rasmussen, B., & Deckert, T.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 1994-02-01
- Volume
- 17
- Issue
- 2
- Pages
- 120-125
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2010025671
- Cited by
- 104
- References
- 0
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Predictive Value of Microalbuminuriq in IPPM: A five-year follow-up study. https://app.cochat.ai/papers/10.2337/diacare.17.2.120
- The paper
- Almdal, T., Nörgaard, K., Feldt-Rasmussen, B., & Deckert, T. (1994). The Predictive Value of Microalbuminuriq in IPPM: A five-year follow-up study. Diabetes Care. https://doi.org/10.2337/diacare.17.2.120
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.